The Current Ratio of Gilead Sciences, Inc. (GILD) is
1.55.
Current Ratio compares a firm's current assets to its current liabilities to assess short-term liquidity. A ratio above 1.0 typically indicates a strong ability to meet obligations.
| Date |
Value |
| 2025-12-31 |
1.55
|
| 2024-12-31 |
1.60
|
| 2023-12-31 |
1.43
|
| 2022-12-31 |
1.29
|
| 2021-12-31 |
1.27
|
| 2020-12-31 |
1.40
|
| 2019-12-31 |
3.10
|
| 2018-12-31 |
3.38
|
| 2017-12-31 |
2.74
|
| 2016-12-31 |
2.12
|
| Ticker |
Name |
Value |
|
ALLO
|
Allogene Therapeutics, Inc.
|
7.93
|
|
APLS
|
Apellis Pharmaceuticals, Inc.
|
3.14
|
|
HALO
|
Halozyme Therapeutics, Inc.
|
4.66
|
|
MRNA
|
Moderna, Inc.
|
3.29
|
|
SRPT
|
Sarepta Therapeutics, Inc.
|
2.32
|
|
NTLA
|
Intellia Therapeutics, Inc.
|
5.08
|
|
TGTX
|
TG Therapeutics, Inc.
|
6.25
|
|
EBS
|
Emergent BioSolutions Inc.
|
5.01
|
|
UTHR
|
United Therapeutics Corporation
|
6.60
|
|
XLRN
|
Acceleron Pharma Inc
|
14.84
|
|
FATE
|
Fate Therapeutics Inc
|
5.79
|
|
KOD
|
Kodiak Sciences Inc.
|
4.72
|
|
SGEN
|
Seagen Inc
|
3.42
|
|
ASND
|
Ascendis Pharma A/S
|
1.04
|
|
BPMC
|
Blueprint Medicines Corp
|
2.85
|
|
INCY
|
Incyte Corp
|
3.32
|
|
MRTX
|
Mirati Therapeutics Inc
|
6.96
|
|
ALNY
|
Alnylam Pharmaceuticals, Inc.
|
2.76
|
|
AMGN
|
Amgen Inc
|
1.14
|
|
CRSP
|
CRISPR Therapeutics AG
|
13.32
|
|
CVAC
|
CureVac NV
|
7.28
|
|
IONS
|
Ionis Pharmaceuticals, Inc.
|
3.83
|
|
REGN
|
Regeneron Pharmaceuticals, Inc.
|
4.13
|
|
ALKS
|
Alkermes Plc
|
3.55
|
|
BHVN
|
Biohaven Ltd.
|
3.18
|
|
BNTX
|
Biontech SE
|
7.54
|
|
SANA
|
Sana Biotechnology, Inc.
|
1.89
|
|
TPTX
|
Turning Point Therapeutics Inc
|
21.08
|